Washington, D.C. 20549

                                    FORM 8-K

                                CURRENT REPORT
                      PURSUANT TO SECTION 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

        Date of Report (date of earliest event reported): June 30, 2009

                                Aehr Test Systems
             (Exact name of Registrant as specified in its charter)

          California                    000-22893             94-2424084
(State or other jurisdiction of  (Commission File Number)  (I.R.S. Employer
 incorporation or organization)                         Identification Number)

                               400 Kato Terrace
                           Fremont, California 94539
         (Address of principal executive offices, including zip code)

             (Registrant's telephone number, including area code)

         (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02.  Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain

(e)   Additional Stock Option Grant to Non-Employee Directors

      On June 30, 2009, the Compensation Committee of the Board of Directors
(the "Board") of Aehr Test Systems (the "Company") recommended and the Board
approved stock option grants to the Company's non-employee directors.  Each
non-employee director was granted a stock option to purchase 5,000 shares of
the Company's Common Stock.  The option grants vest over 12 months, with 1/12th
vesting after one month and the balance vesting on a monthly pro rata basis
over the remaining period so long as the director continues serving on the
Board.  The exercise price of the option grants is $0.85 per share which was
the closing price of the Company's Common Stock on June 30, 2009.  The option
grants are in addition to the current compensation arrangement for the
Company's non-employee directors and were made pursuant to the Company's 2006
Equity Incentive Plan.


            Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                               Aehr Test Systems
Date:  July 6, 2009
                                          By:   /S/ GARY L. LARSON
                                               Gary L. Larson
                                               Vice President of Finance and
                                               Chief Financial Officer